Avian Pathology

Papers
(The H4-Index of Avian Pathology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
New strategies to prevent and control avian pathogenic Escherichia coli (APEC)48
A unified genotypic classification of infectious bursal disease virus based on both genome segments45
The Avian Pathogenic Escherichia coli (APEC) pathotype is comprised of multiple distinct, independent genotypes41
Clinical expression, epidemiology, and monitoring of Mycoplasma gallisepticum and Mycoplasma synoviae: an update38
Spotlight on avian pathology:Eimeriaand the disease coccidiosis32
Bursa atrophy at 28 days old caused by variant infectious bursal disease virus has a negative economic impact on broiler farms in Japan31
Characterization of antigenic variant infectious bursal disease virus strains identified in South Korea31
The bird’s immune response to avian pathogenic Escherichia coli16
Detection and molecular characterization of a new genotype of infectious bursal disease virus in Portugal16
Minimal inhibitory concentration of seven antimicrobials to Mycoplasma gallisepticum and Mycoplasma synoviae isolates from six European countries16
The pathogenesis of a 2022 North American highly pathogenic clade 2.3.4.4b H5N1 avian influenza virus in mallards (Anas platyrhynchos)16
Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek’s disease viruses16
Omics technologies in poultry health and productivity - part 1: current use in poultry research14
Aerosol is the optimal route of respiratory tract infection to induce pathological lesions of colibacillosis by a lux-tagged avian pathogenic Escherichia coli in chickens13
Epidemiology of fowl adenovirus (FAdV) infections in South Korean chickens during 2013–2019 following introduction of FAdV-4 vaccines13
0.096616983413696